药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Insulin detemir
Reposal
The risk or severity of adverse effects can be increased when Reposal is combined with Levomilnacipran.
Insulin detemir
Ethadione
The risk or severity of adverse effects can be increased when Ethadione is combined with Levomilnacipran.
Insulin detemir
Vinylbital
The risk or severity of adverse effects can be increased when Vinylbital is combined with Levomilnacipran.
Insulin detemir
Mephenoxalone
The risk or severity of adverse effects can be increased when Mephenoxalone is combined with Levomilnacipran.
Insulin detemir
Fazadinium bromide
The risk or severity of adverse effects can be increased when Fazadinium bromide is combined with Levomilnacipran.
Insulin detemir
Cyclobarbital
The risk or severity of adverse effects can be increased when Cyclobarbital is combined with Levomilnacipran.
Insulin detemir
Methylpentynol
The risk or severity of adverse effects can be increased when Methylpentynol is combined with Levomilnacipran.
Insulin detemir
Vinyl ether
The risk or severity of adverse effects can be increased when Vinyl ether is combined with Levomilnacipran.
Insulin detemir
Niaprazine
The risk or severity of adverse effects can be increased when Niaprazine is combined with Levomilnacipran.
Insulin detemir
Mosapramine
The risk or severity of adverse effects can be increased when Mosapramine is combined with Levomilnacipran.
Insulin detemir
Hexapropymate
The risk or severity of adverse effects can be increased when Hexapropymate is combined with Levomilnacipran.
Insulin detemir
Alcuronium
The risk or severity of adverse effects can be increased when Alcuronium is combined with Levomilnacipran.
Insulin detemir
Pridinol
The risk or severity of adverse effects can be increased when Pridinol is combined with Levomilnacipran.
Insulin detemir
Fabomotizole
The risk or severity of adverse effects can be increased when Fabomotizole is combined with Levomilnacipran.
Insulin detemir
Diethyl ether
The risk or severity of adverse effects can be increased when Diethyl ether is combined with Levomilnacipran.
Insulin detemir
Naftidrofuryl
The risk or severity of adverse effects can be increased when Naftidrofuryl is combined with Levomilnacipran.
Insulin detemir
Gallamine
The risk or severity of adverse effects can be increased when Gallamine is combined with Levomilnacipran.
Insulin detemir
Allobarbital
The risk or severity of adverse effects can be increased when Allobarbital is combined with Levomilnacipran.
Insulin detemir
Emylcamate
The risk or severity of adverse effects can be increased when Emylcamate is combined with Levomilnacipran.
Insulin detemir
Thiopropazate
The risk or severity of adverse effects can be increased when Thiopropazate is combined with Levomilnacipran.